Related Experiment Videos

Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion

R A Read1, E E Moore, F A Moore

  • 1Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center 80204-4507.

Surgery
|August 1, 1993
PubMed
Abstract

Insights

Platelet-activating factor (PAF) primes neutrophils, increasing their superoxide production. However, CD11B-mediated adherence to endothelial cells is not essential for this PAF-induced priming process.

Area of Science:

  • Immunology
  • Cellular Biology
  • Inflammation Research

Background:

  • Previous studies link phospholipase A2-dependent platelet-activating factor (PAF) to neutrophil-mediated tissue injury following gut ischemia-reperfusion.
  • A discordance between neutrophil sequestration and tissue injury has been observed.
  • CD11B-dependent neutrophil-endothelial cell adhesion is thought to be crucial for neutrophil-mediated tissue injury.

Purpose of the Study:

  • To investigate the hypothesis that PAF-induced neutrophil superoxide production necessitates CD11B-mediated neutrophil-endothelial cell adherence.

Main Methods:

  • Human neutrophils were isolated and exposed to PAF (10 ng/ml) for up to 120 minutes.
  • Assays were performed to measure superoxide production, CD11B receptor expression, and neutrophil adhesion to endothelial cells.

Main Results:

  • PAF induced rapid changes in neutrophil priming, including increased superoxide production, CD11B receptor expression, and adhesion to endothelial cells.
  • Neutrophil priming correlated temporally with CD11B expression but preceded adhesion.
  • Blocking CD11B reduced neutrophil adhesion but did not affect superoxide production.

Conclusions:

  • PAF-induced neutrophil priming occurs concurrently with CD11B expression and subsequent endothelial cell adherence.
  • CD11B-mediated adherence is not essential for PAF-induced neutrophil priming.

Related Concept Videos